An inverse correlation of human peripheral blood regulatory T cell frequency with the disease activity of ulcerative colitis

被引:97
作者
Takahashi, M
Nakamura, K
Honda, K
Kitamura, Y
Mizutani, T
Araki, Y
Kabemura, T
Chijiiwa, Y
Harada, N
Nawata, H
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, Fukuoka 8128582, Japan
[2] Natl Fukuoka Higashi Med Ctr, Fukuoka, Japan
[3] Saiseikai Fukuoka Gen Hosp, Fukuoka, Japan
[4] Hara Sanshin Hosp, Fukuoka, Japan
关键词
inflammatory bowel disease; colitis; ulcerative; CD4-positive T lymphocyte; interleukin-2 receptor alpha;
D O I
10.1007/s10620-006-3191-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Evidence suggests that CD4(+) CD25(+) regulatory T cells play a crucial role in the suppression of intestinal inflammation. However, their role in the suppression of inflammatory bowel disease has not yet been addressed. We examined the proportion of regulatory T cells in inflammatory bowel disease. First, we isolated CD4(+) CD45RO(+) CD25(+) T cells from the peripheral blood of healthy persons and showed that these cells suppressed T cell proliferation profoundly and expressed FoxP3 abundantly, revealing that they are regulatory cells. Then the proportion of CD45RO(+) CD25(+) in peripheral blood CD4(+) T cells was analyzed in patients and healthy controls by flow cytometry. CD4(+) CD45RO(+) CD25(+) T cell frequency was significantly lower in active ulcerative colitis than in the control and inactive ulcerative colitis. CD4(+) CD45RO(+) CD25(+) T cell frequency was inversely correlated with the clinical and endoscopic severity of ulcerative colitis. These results suggest that a deficiency of regulatory T cells is associated with the progression of ulcerative colitis.
引用
收藏
页码:677 / 686
页数:10
相关论文
共 37 条
[31]  
2-Q
[32]   Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells:: induction of autoimmune disease by breaking their anergic/suppressive state [J].
Takahashi, T ;
Kuniyasu, Y ;
Toda, M ;
Sakaguchi, N ;
Itoh, M ;
Iwata, M ;
Shimizu, J ;
Sakaguchi, S .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (12) :1969-1980
[33]   The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality [J].
Taylor, PA ;
Lees, CJ ;
Blazar, BR .
BLOOD, 2002, 99 (10) :3493-3499
[34]   CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production [J].
Thornton, AM ;
Shevach, EM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (02) :287-296
[35]   Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis [J].
Viglietta, V ;
Baecher-Allan, C ;
Weiner, HL ;
Hafler, DA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (07) :971-979
[36]   X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy [J].
Wildin, RS ;
Ramsdell, F ;
Peake, J ;
Faravelli, F ;
Casanova, JL ;
Buist, N ;
Levy-Lahad, E ;
Mazzella, M ;
Goulet, O ;
Perroni, L ;
Bricarelli, FD ;
Byrne, G ;
McEuen, M ;
Proll, S ;
Appleby, M ;
Brunkow, ME .
NATURE GENETICS, 2001, 27 (01) :18-20
[37]   Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells [J].
Yagi, H ;
Nomura, T ;
Nakamura, K ;
Yamazaki, S ;
Kitawaki, T ;
Hori, S ;
Maeda, M ;
Onodera, M ;
Uchiyama, T ;
Fujii, S ;
Sakaguchi, S .
INTERNATIONAL IMMUNOLOGY, 2004, 16 (11) :1643-1656